Pharmacy Premises / pharmacy Manufacture / Pathology laboratory General Premises / Royal College of Physicians / /
IndustryTerm
investigational medicinal product / investigational medicinal products / pharmaceutical industry / body systems / trial protocol / trial site / dose-escalation protocols / facilities equipment / risk management / medicinal products / food / /
MedicalCondition
disease / target disease / specific disease / /
MedicalTreatment
Gene therapy / Resuscitation / /
Organization
Food and Drug Administration / University of Sheffield / Royal College of Physicians / European Medicines Agency / MHRA / European Commission / Committee for Medicinal Products for Human Use / European Union / Malcolm Boyce Association for Human Pharmacology / UK Commission on Human Medicines / ABPI / /
Person
Oliver Schmidt / /
Position
investigator / General Practitioner / Professor of Molecular Medicine / Chairman / Pathology laboratory General / Radioactive substances General / report and publication General Data management / General / /
Guidelines for phase 1 clinical trials 2012 edition Foreword The development of new and better medicines is vital for the public health. A key step in